NCT03031938 2021-06-25Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical StudiesPfizerPhase 3 Completed4 enrolled 78 charts
NCT02519387 2016-07-20Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate IntensityMundipharma Pharmaceuticals Sdn. Bhd.Phase 4 Completed78 enrolled 9 charts